After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Background Transcatheter aortic-valve replacement (TAVR) is an alternative to surgery in
patients with severe aortic stenosis who are at increased risk for death from surgery; less is …

Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …

Background Although transcatheter aortic-valve replacement (TAVR) is an accepted
alternative to surgery in patients with severe aortic stenosis who are at high surgical risk …

Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …

5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Abstract Background: The CoreValve US Pivotal High Risk Trial was the first randomized
trial to show superior 1-year mortality of transcatheter aortic valve replacement (TAVR) …

Although surgery was the mainstay of treatment for valvular heart disease, transcatheter
valve therapies have grown exponentially over the past decade. Two types of artificial heart …